Target intelligence / Profile preview

Autophagy-related protein 101 (ATG101)

Target
ATG101
Molecular classification
Other (autophagy complex component; contains a HORMA domain)
01

Overview

Autophagy-related protein 101 (ATG101) is a highly conserved cytoplasmic protein encoded by the *C12orf44* gene in humans[1]. ATG101 is a core component of the ULK (unc-51-like kinase) initiation complex that orchestrates the early steps of autophagy, a catabolic process critical for cellular homeostasis, stress response, and degradation of cytoplasmic constituents[1][2][3]. ATG101 contains a HORMA domain that adopts an open conformation and forms a stable heterodimer with ATG13, another ULK complex subunit[2][4]. Through this interaction, ATG101 protects ATG13 from proteasomal degradation and thus maintains ULK1 complex integrity, which is necessary for autophagosome formation in response to nutrient deprivation or cellular stress[1][2][3][4]. Structural studies reveal that ATG101's unique HORMA fold and a specialized WF finger motif make it an interaction hub within the autophagy machinery, recruiting downstream effectors to the site of autophagosome initiation[3][4]. Recent research links altered ATG101 expression to several cancers, including cholangiocarcinoma, colon cancer, and hepatocellular carcinoma, suggesting its utility as a disease biomarker and its conceptual potential as a drug target[3]. However, to date, no specific drugs or small molecules are known to directly target ATG101 in clinical or experimental settings. Perturbation of ATG101 or the entire ULK complex can severely disrupt autophagy, raising concerns about cell viability if targeted indiscriminately[3].

Other names
C12orf44PP894FLJ11773Atg13-interacting proteinATG101autophagy-related protein 101Atg101
02

Biological functions

Autophagy initiationRegulation of protein stabilityRegulation of autophagosome assemblyNegative regulation of cell proliferationRegulation of protein lipidation
03

Disease associations

Cancer (biomarker in cholangiocarcinoma, colon cancer, hepatocellular carcinoma)Other (as a regulator of autophagy, implicated in diseases involving defective autophagy mechanisms)
04

Safety considerations

Potential effect on essential cellular autophagybroad modulation may risk cell viability and homeostasis
05

Biomarkers

CholangiocarcinomaColon cancerHepatocellular carcinoma

Beyond the preview

Go deeper on Autophagy-related protein 101 (ATG101).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy-related protein 101 (ATG101).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call